Complex Assets.
Integrated Expertise.
One European Team.
Life Science Real Estate is complex by nature. Scientific processes, user requirements, specialised buildings, regulation, capital markets and local ecosystems all need to be understood together.
HELIX alpha therefore brings together complementary expertise across Life Sciences, Corporate Real Estate, investment management, specialised real estate, law and academia. Our European representatives add first-hand market knowledge and established networks across key Life Science locations.
Together, we operate as one integrated European team – combining different perspectives around a shared understanding of Life Science Real Estate.
Leadership Team
Bringing together investment management, Life Science, real estate, legal and governance expertise.
CEO / Managing Partner
Chair Investment & Risk Committee
Martin Eberhardt FRICS
Martin is a Fellow of the Royal Institution of Chartered Surveyors (RICS) and holds an MBA (Diplom-Kaufmann) as well as a degree in Real Estate Economics from the European Business School (EBS).
He has held managing director and executive-level positions in the real estate investment industry since 2000, including leadership roles at Colliers Grossmann & Berger, Union Investment Institutional Property, Bouwfonds IM (Rabobank Group), Corpus Sireo / Swiss Life KVG, and Corestate Capital / Hannover Leasing.
His experience also includes extensive work in corporate real estate, where he served as project manager for Daimler-Benz Real Estate and later oversaw the entire real estate asset management at Deutsche Telekom.
Beyond his executive roles, Martin has served in several honorary positions within leading industry associations, including as Chairman of the Board of RICS (Royal Institution of Chartered Surveyors) Germany (2013–2020), member of the RICS Governing Council in London (2020–2023), member of the presidium of the German Property Federation (ZIA, 2015–2020), and board member of CoreNet Global at both the German and European levels (1996–2005).
Managing Partner
Member Investment & Risk Committee
Patrick Schlump
Patrick studied Business Administration in Oestrich-Winkel (European Business School) and holds a Master’s degree in Real Estate Investment from the University of Reading, UK.
He has extensive experience in institutional real estate & infrastructure investment management, with positions at Union Investment, Bouwfonds Investment Management (Rabobank), Corpus Sireo / Swiss Life and Praemia REIM.
His experience spans strategy and business development, the structuring and management of institutional real estate investment products and specialised real estate sectors. Most recently, at Praemia REIM, his activities focused on healthcare real estate.
At HELIX alpha, he combines this academic and institutional investment background with extensive experience in fund management and working with institutional investors.
At Union Investment, Bouwfonds Investment Management and Corpus Sireo / Swiss Life, he worked alongside Martin at different stages of their careers.
Director Advisory/
Member Investment & Risk Committee
Dr. Thomas Diefenthal
Thomas holds a degree in Biology with a specialization in genetics from the University of Cologne and received his PhD from the Max Planck Institute for Plant Breeding Research. After serving as project manager and research coordinator at the Weißheim research division in collaboration with the Carlsberg Research Laboratory in Copenhagen, he became Managing Partner of Maltagen Forschungs GmbH from 1994 to 1999.
Since 1999, Thomas has been Managing Director of BioPark Regensburg GmbH, where he has overseen the development of one of Bavaria’s largest biotech innovation and start-up centers. Built in three phases on the university campus, the BioPark now comprises 18,000 square meters with 37 tenants and 683 employees. He also coordinates the BioRegio Regensburg cluster in Eastern Bavaria, certified with the European Cluster Excellence Label in Silver and currently encompassing 66 life-science companies with approx. 5.500 employees.
Thomas has been deeply involved in the national innovation ecosystem and served for many years as Vice President of the German Association of Innovation, Technology, and Start-Up Centers.
General Counsel /
Member Investment & Risk Committee
Dr. Michael Jani
Michael is a seasoned real estate lawyer with a strong focus on investment structures for institutional clients. After studying law at the Universities of Kiel and Guildford/Surrey (UK), he has dedicated his career to real estate law since 1995.
As Of Counsel at GSK Stockmann, he combines deep legal expertise with a practical understanding of transactions, project development, fund structuring, and the regulatory aspects of real estate investments.
Michael and Martin have worked together successfully on numerous investment-related projects and transactions.
Advisory Board
Independent strategic, scientific, Life Science industry and corporate real estate expertise
The Advisory Board holds a seat and voting right on HELIX alpha’s Investment & Risk Committee, integrating its expertise directly into investment and risk decisions
Chairman Advisory Board
Prof. Dr. Thomas Glatte
Thomas is an experienced real estate executive and professor of real estate management.
After starting his career as a construction manager for the Philipp Holzmann Group in Thailand and India, he joined BASF in 1998, where he advanced into corporate real estate management. From 2005 to 2022, he served as Director Global Real Estate, overseeing the BASF Group’s worldwide real estate activities.
His previous work at the BASF pension fund also gives him a clear understanding of the needs of institutional investors.
In addition to his corporate career, Thomas has held a professorship in Real Estate Economics at Hochschule Fresenius in Heidelberg since 2019, focusing on sustainable real estate investments, project development, and real estate & facility management.
He has been actively engaged in leading industry associations, including serving on the board of CoreNet Global since 2008 and as a member of the DGNB Real Estate Advisory Board since 2017.
Since 2022, Thomas has been the CEO of a mid-sized corporate group that manages its own real estate portfolios and provides integrated real estate services across Germany.
Member Advisory Board
Dr. Inez de Greef
Inez is Co-Founder and Managing Partner of 3D-PharmXchange and serves as CEO of the biotechnology company Treeway.
As a strategic leader in the life sciences sector, she has built her career at the intersection of science, entrepreneurship, and innovation. Prior to founding 3D-PharmXchange in 2010, she held roles at Tibotec-Virco (now Johnson & Johnson) and Kinesis Pharma, gaining extensive experience in drug development and translational research.
Since 2013, Inez has also led Treeway, advancing novel therapies for neurodegenerative diseases with a primary focus on ALS and Alzheimer’s. In this capacity she combines visionary leadership with a strong translational mindset, fostering collaboration between science, investors, and industry to accelerate meaningful impact for patients.
She brings a deep understanding of the entire life-science innovation lifecycle, from early research to commercialization. Inez is a Fellow of the Netherlands Academy of Engineering and contributes her expertise across several advisory and strategic boards.
![Andreas Pfnür, HELIX alpha Copyright TU Darmstadt, Lydia Tomchuk[57]_edited_edited.jpg](https://static.wixstatic.com/media/e64ac3_f33a3ca660f84893a077463baadd4482~mv2.jpg/v1/crop/x_72,y_27,w_1144,h_950/fill/w_402,h_334,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/Andreas%20Pfn%C3%BCr%2C%20HELIX%20alpha%20Copyright%20TU%20Darmstadt%2C%20Lydia%20Tomchuk%5B57%5D_edited_edited.jpg)
Member Advisory Board
Prof. Dr. Andreas Pfnür
Andreas is Head of the Real Estate and Construction Management Department at the Faculty of Law and Economics at Technical University Darmstadt.
He serves on the board of the German Institute for Real Estate Economics, is a board member of BPPP e.V. Network Infrastructure Management, and a member of the International Scientific Advisory Board of the International Facility Management Association (IFMA).
He regularly advises corporations, government entities, and industry associations on strategic real estate matters. His current research focuses on corporate real estate management—particularly within the life science sector—real estate project development, investment management, and the broader transformation of the real estate industry.
European Representatives
Local insight and established networks across key European Life Science Real Estate markets.
Country Representative - France
Dominique Dudan FRICS
Dominique is a Fellow of the Royal Institution of Chartered Surveyors (RICS) and has been actively involved with RICS in France for many years.
In recognition of her contributions to the real estate industry, she was awarded the title Chevalier de l’Ordre National du Mérite.
She is regarded as a recognized expert in French investment management with an excellent institutional network. Her career includes senior positions at Union Investment, where she served as CEO of the French fund platform, HSBC REIM, and BNP Paribas REIM.
Prior to that, she worked for the Accor Group as Development Director. Today, she also serves as an independent board member/director at the listed real estate companies Gecina and Mercialys.
Dominique and Martin not only worked together successfully and in spirit of trust at Union Investment, but also maintained close professional ties through their respective voluntary leadership roles within RICS.
Regional Representative - Nordics
Mikael Wadsten
Mikael is an entrepreneur and senior executive with extensive international experience in the real estate sector and adjacent industries.
His focus is on specialized real estate segments, particularly healthcare real estate, life science properties, and corporate housing, which he develops in close collaboration with users, academic institutions, and international capital partners.
For more than 13 years, he served as Regional Manager Nordics & Baltics at RICS, where he helped build the organization in Sweden and Finland, further developed the presence in Denmark, and supported expansion into the Baltic states.
Prior to this, he founded and led the media platform Realplay as Founder & CEO.
Mikael and Martin know and value each other trough their joint leadership roles within RICS Europe.
Country Representative - Spain
Manuel Tabuyo
Manuel is co-founder of SALTA Real Estate, a Spanish advisory firm providing strategic and transaction-related services for developers, investors, and funds.
He brings more than 25 years of experience across multiple asset classes (including residential, retail, logistics, and alternatives) and has strong institutional expertise from his time at ING Real Estate, where he spent most of his professional career, including regulated investment structures and close cooperation with institutional investors.
Through SALTA, he advises national and international clients on acquisitions, developments, and market strategies.
Manuel supported Bouwfonds IM during its strategic entry into the Spanish residential market, during Martin's tenure as Managing Director.
Country Representative - Spain
Ignacio Salvador
Ignacio is also a co-founder of SALTA Real Estate and, like Manuel Tabuyo, has more than 25 years of market experience across various real estate segments and in advising institutional players.
He previously worked at ING Real Estate and brings long-standing expertise in investment and transaction processes.
Other career stations include JLL, Aktua, Carrefour, Caprabo, Continente (Promodes Group), and Dragados Real Estate. At SALTA, his focus is on advising on acquisitions, development projects, and the implementation of market entry and growth strategies.